Annals of Translational Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2021-09-15 lucky123

审稿速度:4.0 | 投稿命中率:25.0
偏重的研究方向：转化医学
经验分享：请问大家under review （step1）是什么意思？是送外审了吗？

297 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-06-27 14618cfam12暂无昵称

3.9分，编辑可能以为该杂志9.9分，凡尔赛

33 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-11-07 532945060_90445959

请问大家的under review(step6)都持续了多久呢。。

200 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-06-06 1e235a1cm31(暂无匿称)

4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！

76 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-07-13 haohaoxuexiya

这个杂志有可能水掉

184 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-06-24 1e1a5a91m86(暂无匿称)

唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态

134 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-07-04 angela460314_78893648

5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢

120 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2020-05-22 148944d7m46暂无昵称

meta投稿两天后志杰被拒，速度真快~没有理我~

129 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-07-04 爱科研的小博士

偏重的研究方向：肿瘤
经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051565, encodeId=a3be105156583, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：转化医学 经验分享：请问大家under review （step1）是什么意思？是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/23/9a403f3eabc61640e3d5b426cb41c76a.jpg, createdBy=32da2477800, createdName=lucky123, createdTime=Wed Sep 15 18:59:55 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228910, encodeId=c0241228910c6, content=3.9分，编辑可能以为该杂志9.9分，凡尔赛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6935111920, createdName=14618cfam12暂无昵称, createdTime=Mon Jun 27 09:23:15 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897570, encodeId=c4b789e570f7, content=请问大家的under review(step6)都持续了多久呢。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=988e2100762, createdName=532945060_90445959, createdTime=Sat Nov 07 14:10:18 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601672, encodeId=41a76016e2fb, content=4月7日投稿，至今两月了，毫无音讯，不知是否应该发封邮件咨询下编辑？希望过来人给点经验，谢谢大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=82052031183, createdName=1e235a1cm31(暂无匿称), createdTime=Sat Jun 06 21:26:28 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802625, encodeId=a73a80262553, content=这个杂志有可能水掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/9e248a7c9c204fb385d376d5404f9e85/timg.jpg, createdBy=2c5b1954110, createdName=haohaoxuexiya, createdTime=Mon Jul 13 10:39:49 CST 2020, time=2020-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799558, encodeId=76d7e995586d, content=唉，一审用了一个月左右，小修后从四月中旬到现在一直是in review 的状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=477f1991164, createdName=1e1a5a91m86(暂无匿称), createdTime=Wed Jun 24 12:46:57 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801225, encodeId=2d8c801225d6, content=5月12日投稿，一直是in review状态，中间日期变化了3次了，啥时候有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=81d32290624, createdName=angela460314_78893648, createdTime=Sat Jul 04 20:17:39 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591525, encodeId=a496591525d2, content=meta投稿两天后志杰被拒，速度真快~没有理我~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcd95314293, createdName=148944d7m46暂无昵称, createdTime=Fri May 22 00:00:00 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230553, encodeId=40251230553a4, content=偏重的研究方向：肿瘤 经验分享：Archived持续了3个星期，正常吗？怎么回事，是被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06495470307, createdName=爱科研的小博士, createdTime=Mon Jul 04 20:54:18 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239512, encodeId=af4d1239512ec, content=偏重的研究方向：肿瘤 经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5191972709, createdName=1e16519dm57(暂无匿称), createdTime=Thu Aug 18 13:31:08 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

2022-08-18 1e16519dm57(暂无匿称)

偏重的研究方向：肿瘤
经验分享：请问大家，投稿三天后，状态变为archi ved 是拒稿了吗？怎么也不发个邮件明确告知一下？

69 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务